Manipal Health IPO Secures Rs 4,167 Crore from Anchor Investors, Including ADIA and Morgan Stanley.

Manipal Health Enterprises Ltd is set to launch its initial public offering (IPO) on July 29, raising Rs 4,167 crore through an anchor investment round. The company has garnered interest from various global investors such as the Abu Dhabi Investment Authority (ADIA) and Goldman Sachs Bank Europe, among others. The IPO price band has been fixed between Rs 560 to Rs 590 per share, which values the company at over Rs 77,600 crore at the upper end of the band. The three-day public issue aims to close on July 31, featuring a fresh issue and an offer for sale by existing shareholders, including several prominent private equity firms.

The anchor investment has garnered positive sentiment in the grey market, reflecting investor confidence ahead of the public offering. The substantial participation from a diverse group of institutional and global investors suggests a strong belief in Manipal Health’s business model and future prospects. Investors have already shown enthusiasm in the pre-IPO phase, which is often a promising indicator for the stock’s performance after its public release.

For Indian investors, the upcoming listing on the BSE and NSE represents a significant opportunity to invest in a well-established healthcare player operating a pan-India network of multispecialty hospitals. With the company’s recent performance, including robust revenue and profit figures, the IPO could attract substantial interest, especially among qualified institutional buyers and retail investors alike. The allocation structure provides a fair share for all categories, enhancing accessibility for ordinary investors to participate in what appears to be a growth-oriented venture in the Indian healthcare market.

Source: The Economic Times

(Expert Note: This report was prepared by the Wealthova IPO team.)